Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
1.470
-0.060 (-3.92%)
At close: Aug 1, 2025, 4:00 PM
1.480
+0.010 (0.68%)
After-hours: Aug 1, 2025, 7:57 PM EDT
Mustang Bio Market Cap
Mustang Bio has a market cap or net worth of $6.43 million as of August 1, 2025. Its market cap has decreased by -79.18% in one year.
Market Cap
6.43M
Enterprise Value
-7.80M
1-Year Change
-79.18%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since August 22, 2017, Mustang Bio's market cap has decreased from $7.60B to $6.43M, a decrease of -99.92%. That is a compound annual growth rate of -58.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 6.70M | -58.42% |
| Dec 31, 2024 | 16.10M | -76.42% |
| Dec 29, 2023 | 68.28M | -76.63% |
| Dec 30, 2022 | 292.22M | -75.76% |
| Dec 31, 2021 | 1.21B | -54.39% |
| Dec 31, 2020 | 2.64B | -3.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.35B |
| Johnson & Johnson | 402.82B |
| AbbVie | 334.40B |
| UnitedHealth Group | 241.34B |
| AstraZeneca | 236.88B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |